sellModerate cluster of 2
William Garrett Gray sold $272k of CKPT
Chief Financial Officer at Checkpoint Therapeutics, Inc.. 74,110 shares at an average of $3.67, traded Feb 6, 2025, filed Feb 7, 2025.
Warning score
43Value
$272k
74,110 shares
Holdings after
1,458,644
-5% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +22RoleCFO
- +13Trade size$272k at market
- 0Share of holdings soldSold 4.8% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001104659-25-010662, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 6, 2025 | SOpen-market sale COMMON STOCK | -74,110 | $3.67 | $272k | 1,458,644 | Feb 7, 2025 |
Related signals
Other insiders at Checkpoint Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | CKPTsell Checkpoint Therapeutics, Inc. | Fortress Biotech, Inc. owner | $129k 100,000 shares | -2% | |
| 37Weak | Checkpoint Therapeutics, Inc. | William Garrett Gray Chief Financial Officer | $50k 12,322 shares | -1% | |
| 40Moderate | Checkpoint Therapeutics, Inc. | James F Oliviero III CEO, President and Director | $61k 15,090 shares | -0% | |
| 41Moderate | Checkpoint Therapeutics, Inc. | James F Oliviero III CEO, President and Director | $64k 19,564 shares | -1% | |
| 60Notable | Checkpoint Therapeutics, Inc. | William Garrett Gray Chief Financial Officer | $1.1M 268,432 shares | -21% | |
| 63Notable | Checkpoint Therapeutics, Inc. | James F Oliviero III CEO, President and Director | $3.1M 822,397 shares | -20% | |
| 35Weak | Checkpoint Therapeutics, Inc. | William Garrett Gray Chief Financial Officer | $27k 13,038 shares | -2% | |
| 40Moderate | Checkpoint Therapeutics, Inc. | James F Oliviero III CEO, President and Director | $50k 24,610 shares | -1% | |
| 30Weak | Checkpoint Therapeutics, Inc. | William Garrett Gray Chief Financial Officer | $4,212 2,035 shares | -1% | |
| 33Weak | Checkpoint Therapeutics, Inc. | James F Oliviero III CEO, President and Director | $12k 5,894 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.